UI

UC Investments

North America, California, United States, Oakland

Description

UC Investments focuses on long-term growth, sustainability, and fiduciary responsibility.

Investor Profile

UC Investments has backed more than 11 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series E rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
  • Led 1 rounds in the past year.

Stage Focus

  • Series B (36%)
  • Series A (18%)
  • Series E (9%)
  • Series H (9%)
  • Series D (9%)
  • Series F (9%)
  • Seed (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • Therapeutics
  • Machine Learning
  • Biopharma
  • Clinical Trials
  • Medical
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UC Investments frequently co-invest with?

UCB Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
BF
North America, California, United States, Berkeley
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Spur Capital Partners
North America, Oklahoma, United States, Bartlesville
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 5

Which angels does UC Investments often collaborate with?

Shared Deals: 1

What are some of recent deals done by UC Investments?

LMArena

San Francisco, California, United States

LMArena focused on building a neutral, open, community-driven platform.

Artificial Intelligence (AI)CommunitiesMachine LearningProduct Research
SeedMay 21, 2025
Amount Raised: $100,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series DFeb 26, 2025
Amount Raised: $350,700,000
Horizon Surgical Systems

Malibu, California, United States

Horizon Surgical Systems develops AI-driven, imaging-guided surgical robotics for microsurgery.

Artificial Intelligence (AI)Health CareRobotics
Series AOct 16, 2024
Amount Raised: $30,000,000
Digestiva

Sacramento, California, United States

Digestiva develops the nutritional, sensory, and physiological properties of food and feed proteins with targeted biocatalysts.

Biotechnology
Series AJul 15, 2024
Amount Raised: $18,400,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 10, 2024
Amount Raised: $158,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 13, 2023
Amount Raised: $158,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series BJan 6, 2022
Amount Raised: $518,000,000
Databricks

San Francisco, California, United States

Databricks is an AI cloud data platform that interacts with corporate information stored in the public cloud.

AnalyticsArtificial Intelligence (AI)Information TechnologyMachine Learning
Series HAug 31, 2021
Amount Raised: $1,600,000,000